NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
78.65 -1.15 (-1.44%) GOLD FUTURES
2,424.20 -14.30 (-0.59%) DOW
39,819.71 +12.94 (+0.03%) Bitcoin GBP
54,991.47 +1,713.25 (+3.22%)
DexCom, Inc. (0A4M.L)
- Business Wire
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
LONDON, May 20, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily tracks real-time glucose readings to help improve diabetes management, and the Dexcom State of Type 2 Report. The report is a first-of-its-kind look at the Type 2 landscape today and examines the preferences and behaviours of those living with the condition, as well as their caretaker
- Zacks
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
- GuruFocus.com
Insider Sale: EVP Strategy and Corporate Development Matthew Dolan Sells Shares of DexCom Inc (DXCM)
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
